Vector Development
Reports advance knowledge in vector development research
Published in Gene Therapy Weekly, February 2nd, 2006
Study 1: Researchers review the cellular factors influencing Semliki Forest Virus vector biology in a recent issue of Gene Therapy.
According to the review from France, "Viral vectors are currently the best tools for gene delivery in a therapeutic setting, especially for in vivo use. Alphaviruses, a family of positive single-stranded RNA viruses, have been engineered to allow the formation of a highly efficient replicon. Using these replicons, it is possible to generate recombinant particles. Parental viruses and recombinant vectors share certain pathways while...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-02-02)
More Articles from Gene Therapy Weekly
- DNA Research
Cationic liposomes permit naked plasmid DNA uptake in human macrophages - Gene Therapy
Cell-permeable HBV-like particles allow efficient gene transfer into hepatocytes - Gene Therapy
Engineered T lymphocytes resist cytokine withdrawal-induced apoptosis - Hepatitis B Virus
Hepatitis B virus replication is inhibited by various RNAi constructs - Addiction Medicine
Gene transfer of GLT-1 attenuates morphine-induced place preference in rats - Antisense Technology
Antisense treatment influences E-cadherin in human gastric carcinoma cells - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
